Changes in drug prescription and reduction of hospital mortality in patients with acute myocardial infarction;Cambios e la prescripción de medicamentos y reduccion de la mortalidad intrahospitalaria en pacientes con infarto agudo del miocardio

Investigacion Cardiovascular

Volumn 6, Issue 2, 2003, Pages 99-108

  Prieto Dominguez J C ^a   Corbalan R ^b   Chavez E ^b   Lanas, F ^b   Cumsille, F ^b   Nazzal, C ^b  

^a HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

^b NONE

Author keywords

ACEIs; Acute myocardial infarction; Aspirin; Beta blockers; Drug treatment; Therapeutic guidelines

Indexed keywords

ACETYLSALICYLIC ACID; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT; NITRATE;

ACUTE HEART INFARCTION; ADULT; AGE; ARTICLE; CARDIOVASCULAR RISK; CHILE; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GENDER; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRACTICE GUIDELINE; PRESCRIPTION; PROSPECTIVE STUDY; REGISTER; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL;

EID: 0344465985     PISSN: 11392096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. ISIS I (First International Study of Infarct Survival Collaborative Group). Randomized trial of intravenous atenolol among 16,027 cases of suspected myocardial infarction. Lancet. 1986; 2: 57-66.
2. ISIS 2 (Second International Study of Infarct Survival Collaborative Group). Randomized trial of intravenous streptokinasa, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction. Lancet. 1988; 2: 349-360.
3. GISSI (Gruppo Italiano per lo Studio della Streptochinasi nell' Infarto Miocardico). Effectiveness of intraveneous thrombolytic treatment in acute myocardial infarction. Lancet. 1986; 1: 397-401.
4. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1,000 patients. Lancet 1994; 343: 311-322.
5. PFEFFER M A, BRAUNWALD E, MOYÉ L A, BASTA L, BROWN J, CUDDY T E, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. N Engl J Med. 1992; 327: 669-677.
6. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993; 342: 821-828.
7. GISSI 3 (Gruppo Italiano per lo Studio della Sodravvivenza nell' Infarto Miocardico). Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 1994; 343: 1115-1122.
8. ISIS 4. A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet. 1995; 345: 669-685.
9. Chinese Cardiac Study Collaborative Group. Oral captopril versus placebo among 13,634 patients with suspected acute myocardial infarction, interim report from the Chinese Cardiac Study. Lancet 1995; 345: 686-687.
10. MATTHEI R, GUARDA E, YOVANOVICH J, CHAMORRO H, PRIETO J C, CORBALÁN R. Recomendaciones para el manejo intrahospitalario del infarto agudo del miocardio. Revista Chilena de Cardiología. 1997; 16: 35-50.
11. Grupo de Estudio Multicéntrico del Infarto (GEMI). ¿Es Posible para la Cardiología Chilena Realizar Estudios Multicéntricos? Revista Chilena de Cardiología. 1993; 12: 153-160.
12. MARTÍNEZ M, AGUSTÍ A, ARNAU J M, VIDAL X, LAPORTE J-R. Trends of prescribing patterns for the secondary prevention of myocardial infarction over a 13 year period. Eur J Clin Pharmacol. 1998; 54: 203-208.
13. ROGERS W J, BOWLBY L J, CHANDRA N C, FRENCH W J, GORE J, LAMBREW C T, et al. Treatment of Myocardial Infarction in the United States (1990-1993). Observations from the National Registry of Myocardial Infarction. Circulation. 1994; 90: 2103-2114.
14. FRENCH W. Trends in Acute Myocardial Infarction Management. Use of The National Registry of Myocardial Infarction in Quality Improvement. Am J Cardiol. 2000; 85: 5B-9B.
15. BOSCH X, SAMBOLA A, ARÓS F, LÓPEZ-BESCÓS L, MANCISIDOR X, et al. Utilización de la trombolisis en los pacientes con infarto agudo del miocardio en España: observaciones del estudio PRIAMHO. Rev Esp Cardiol. 2000; 53: 490-501.
16. European Secondary Prevention Study Group. Translation of clinical trials into practice: a European population-based study of the use of thrombolysis for acute myocardial infarction. Lancet. 1996; 347: 1203-1207.
17. PRIETO J C, CORBALÁN R, CHÁVEZ E, LANAS F, CUMSILLE F, NAZZAL C a nombre del Grupo de Estudio Multicéntrico del Infarto (GEMI). Infarto Agudo del Miocardio en Hospitales Chilenos. Resultados finales del estudio GEMI. Revista Macedica de Chile. 1999; 127: 763-774.
18. LANAS F, PRIETO J C, CHÁVEZ E, CORBALÁN R, CUMSILLE F. Uso de bloqueadores beta-adrenérgicos en el infarto del miocardio. Revista Chilena de Cardiología. 1998; 17: 205-212.
19. KRUMHOLZ H, RADFORD M, WANG Y, CHEN J, MARCINIAK T. Early β-blocker therapy for acute myocardial infarction in elderly patients. Ann Intern Med. 1999; 131: 648-654.
20. YUSUF S, ANAND S, AVEZUM A, FLATHER M, COUTINHO M. Treatment for acute myocardial infarction. European Heart Journal. 1996; 17 (suppl F): 16-29.
21. LATINI R, MAGGIONI A P, FLATHER M, SLEIGHT P, TOGNONI G. ACE inhibitor use in patients with myocardial infarction: summary of evidence from clinical trials. Circulation. 1995; 92: 3132-3137.
22. MCLAUGHLIN T J, SOUMERAI S B, WILLISON D J, GURWITZ J H, BORBAS C, GUADAGNOLI E, et al. Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for undertreatment in women and the elderly. Arch Intern Med. 1996; 156:799-805.
23. FURBERG C D, PSATY B M, MEYER J V. Nifedipine dose related increase in mortality in patients with coronary heart disease. Circulation. 1995; 92: 1326-1331.